Cost-effectiveness analysis of fluticasone furoate/umeclidinium bromide/vilanterol and umeclidinium bromide/vilanterol in the management of moderate and severe COPD in China
Article in Respiratory Medicine (April 2024)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
Article in Respiratory Medicine (April 2024)
Article in Tuberculosis and Respiratory Diseases (February 2024)
Article in Respiratory Medicine (January 2024)